Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds

Molecules

Volumn 19, Issue 4, 2014, Pages 4880-4896

  Sadowska Bartosz, Izabela ^a   Galiniak, Sabina ^a   Bartosz, Grzegorz ^a,b  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidants; Glycation; Glyoxal; Kinetics; Methylglyoxal

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA-CYANO-4-HYDROXYCINNAMATE; AURANTIIN; BOVINE SERUM ALBUMIN; COUMARIC ACID; ELLAGIC ACID; FLAVANONE DERIVATIVE; GENISTEIN; GLYOXAL; KYNURENINE; METHYLGLYOXAL; N'-FORMYLKYNURENINE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; CHEMISTRY; GLYCOSYLATION; KINETICS; OXIDATION REDUCTION REACTION; SPECTROFLUOROMETRY;

ANIMALS; CATTLE; COUMARIC ACIDS; ELLAGIC ACID; FLAVANONES; GENISTEIN; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; KINETICS; KYNURENINE; OXIDATION-REDUCTION; PYRUVALDEHYDE; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE;

EID: 84899510569     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19044880     Document Type: Article

References (53)

1. Seidler, N.W. Basic biology of GAPDH. Adv. Exp. Med. Biol. 2013, 985, 1-36.
2. Rondeau, P.; Bourdon, E. The glycation of albumin: Structural and functional impacts. Biochimie 2011, 93, 645-658.
3. Kalapos, M.P. Methylglyoxal in living organisms. Chemistry; biochemistry; toxicology and biological implications. Toxicol. Lett. 1999, 110, 145-175.
4. McLellan, A.C.; Thornalley, P.J.; Benn, J.; Sonksen, P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complication. Clin. Sci. 1994, 87, 21-29.
5. Thornalley, P.J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-Role in ageing and disease. Drug Metabol. Drug Interact. 2008, 23, 125-150.
6. Turk, Z. Glycotoxines; carbonyl stress and relevance to diabetes and its complications. Physiol. Res. 2010, 59, 147-156.
7. Tarwadi, K.V.; Agte, V.V. Effect of micronutrients on methylglyoxal-mediated in vitro glycation of albumin. Biol. Trace Elem. Res. 2011, 143, 717-725.
8. Lv, L.; Shao, X.; Chen, H.; Ho, C.T.; Sang, S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem. Res. Toxicol. 2011, 24, 579-586.
9. Ihnat, M.A.; Thorpe, J.E.; Ceriello, A. Hypothesis: The metabolic memory; the new challenge of diabetes. Diabet Med. 2007, 24, 582-586.
10. Bento, C.F.; Marques, F.; Fernandes, R.; Pereira, P. Methylglyoxal alters the function and stability of critical components of the protein quality control. PLoS One 2010, 5, e13007.
11. Vistoli, G.; de Maddis, D.; Cipak, A.; Zarkovic, N.; Carini, M.; Aldini, G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic. Res. 2013, 47 (Suppl. 1), 3-27.
12. Muthenna, P.; Akileshwari, C.; Saraswat, M.; Bhanuprakash Reddy, G. Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br. J. Nutr. 2012, 107, 941-949.
13. Aldini, G.; Vistoli, G.; Stefek, M.; Chondrogianni, N.; Grune, T.; Sereikaite, J.; Sadowska-Bartosz, I.; Bartosz, G. Molecular strategies to prevent; inhibit; and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic. Res. 2013, 47 (Suppl. 1), 93-137.
14. Fujiwara, Y.; Kiyota, N.; Tsurushima, K.; Yoshitomi, M.; Mera, K.; Sakashita, N.; Takeya, M.; Ikeda, T.; Araki, T.; Nohara, T.; et al. Natural compounds containing a catechol group enhance the formation of N'-(carboxymethyl)lysine of the Maillard reaction. Free Radic. Biol. Med. 2011, 50, 883-891.
15. Sadowska-Bartosz, I.; Adamczyk-Sowa, M.; Galiniak, S.; Mucha, S.; Pierzchala, K.; Bartosz, G. Oxidative modification of serum proteins in multiple sclerosis. Neurochem. Int. 2013, 6, 507-516.
16. Kaufmann, E.; Boehm, B.O.; Süssmuth, S.D.; Kientsch-Engel, R.; Sperfeld, A.; Ludolph, A.C.; Tumani, H. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2004, 371, 226-229.
17. Anguizola, J.; Matsuda, R.; Barnaby, O.S.; Hoy, K.S.; Wa, C.; DeBolt, E.; Koke, M.; Hage, D.S. Review: Glycation of human serum albumin. Clin. Chim. Acta 2013, 425, 64-76.
18. Bourdon, N.; Loreau, N.; Blache, D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 1999, 13, 233-244.
19. Ramkissoon, J.S.; Mahomoodally, M.F.; Ahmed, N.; Subratty, A.H. Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac. J. Trop. Med. 2013, 6, 561-569.
20. Rezg, R.; El-Fazaa, S.; Gharbi, N.; Mornagui, B. Bisphenol A and human chronic diseases: Current evidences; possible mechanisms; and future perspectives. Environ. Int. 2013, 64C, 83-90.
21. Griffiths, H.R.; Lunec, J.; Blake, D.R. Oxygen radical induced fluorescence in proteins; identification of the fluorescent tryptophan metabolite; N-formyl kynurenine; as a biological index of radical damage. Amino Acids 1992, 3, 183-194.
22. Royer, C.A. Probing protein folding and conformational transitions with fluorescence. Chem. Rev. 2006, 106, 1769-1784.
23. Le Guen, C.A.; Bain, S.; Barnett, A.H; Lunec, J. Captopril inhibits the fluorescence development associated with glycation of proteins. Agents Actions 1992, 36, 264-270.
24. Jakus, V.; Hrnciarová, M.; Cársky, J.; Krahulec, B.; Rietbrock, N. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity. Life Sci. 1999, 65, 1991-1993.
25. Fan, X.; Xiaoqin, L.; Potts, B.; Strauch, C.M.; Nemet, I.; Monnier, V.M. Topical application of L-arginine blocks advanced glycation by ascorbic acid in the lens of hSVCT2 transgenic mice. Mol. Vis. 2011, 17, 2221-2227.
26. Tupe, R.; Agte, V.V. Interaction of zinc; ascorbic acid; and folic acid in glycation with albumin as protein model. Biol. Trace Elem. Res. 2010, 138, 346-357.
27. Krone, C.A.; Ely, J.T. Ascorbic acid; glycation; glycohemoglobin and aging. Med. Hypotheses 2004, 62, 275-279.
28. Vallianou, N.; Evangelopoulos, A.; Koutalas, P. Alpha-lipoic acid and diabetic neuropathy. Rev. Diabet. Stud. 2009, 6, 230-236.
29. Das, UN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med. Sci. Monit. 2006, 12, RA79-RA84.
30. Zhao, W.; Devamanoharan, P.S.; Varma, S.D. Fructose induced deactivation of antioxidant enzymes: Preventive effect of pyruvate. Free Radic. Res. 2000, 33, 23-30.
31. Hegde, K.R.; Varma, S.D. Prevention of cataract by pyruvate in experimentally diabetic mice. Mol. Cell. Biochem. 2005, 269, 115-120.
32. Akberova, S.I.; Musaev, P.I.; Magomedov, N.M.; Babaev, K.F.; Gakhramanov, K.M.; Stroeva, O.G. Para-aminobenzoic acid as an antioxidant. Dokl. Akad. Nauk 1998, 361, 419-421.
33. Greenstock, C.L.; Miller, R.W. The oxidation of tiron by superoxide anion. Kinetics of the reaction in aqueous solution in chloroplasts. Biochim. Biophys. Acta 1975, 396, 11-16.
34. Krishna, C.M.; Liebmann, J.E.; Kaufman, D.; DeGraff, W.; Hahn, S.M.; McMurry, T.; Mitchell, J.B.; Russo, A. The catecholic metal sequestering agent 1;2-dihydroxybenzene-3;5-disulfonate confers protection against oxidative cell damage. Arch. Biochem. Biophys. 1992, 294, 98-106.
35. Soule, B.P.; Hyodo, F.; Matsumoto, K.; Simone, N.L.; Cook, J.A.; Krishna, M.C.; Mitchell, J.B. The chemistry and biology of nitroxide compounds. Free Radic. Biol. Med. 2007, 42, 1632-1650.
36. Bournival, J.; Francoeur, M.A.; Renaud, J.; Martinoli, M.G. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation; nitrosative stress; and apoptosis. Rejuvenation Res. 2012, 15, 322-333.
37. Xie, Y.; Chen, X. Structures required of polyphenols for inhibiting advanced glycation end products formation. Curr. Drug Metab. 2013, 14, 414-431.
38. Obrenovich, M.E.; Nair, N.G.; Beyaz, A.; Aliev, G.; Reddy, V.P. The role of polyphenolic antioxidants in health; disease; and aging. Rejuvenation Res. 2010, 13, 631-643.
39. Razzaghi-Asl, N.; Garrido, J.; Khazraei, H.; Borges, F.; Firuzi, O. Antioxidant properties of hydroxycinnamic acids: A review of structure-activity relationships. Curr. Med. Chem. 2013, 20, 4436-4450.
40. Jang, D.S.; Yoo, N.H.; Kim, N.H.; Lee, Y.M.; Kim, C.S.; Kim, J.; Kim, J.H.; Kim, J.S. 3;5-Di-O-caffeoyl-epi-quinic acid from the leaves and stems of Erigeron annuus inhibits protein glycation; aldose reductase; and cataractogenesis. Biol. Pharm. Bull. 2010, 33, 329-333.
41. Ishibashi, Y.; Matsui, T.; Takeuchi, M.; Yamagishi, S. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Horm. Metab. Res. 2012, 44, 891-895.
42. Ahmad, S.; Shahab, U.; Baig, M.H.; Khan, M.S.; Khan, M.S.; Srivastava, A.K.; Saeed, M.; Moinuddin. Inhibitory effect of metformin and pyridoxamine in the formation of early; intermediate and advanced glycation end-products. PLoS One 2013, 8, e72128.
43. Diamanti-Kandarakis, E.; Alexandraki, K.; Piper, C.; Aessopos, A.; Paterakis, T.; Katsikis, I.; Panidis, D. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Metabolism 2007, 56, 29-134.
44. Ganapathy-Kanniappan, S.; Kunjithapatham, R.; Geschwind, J.F. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: Specific molecular targeting. Anticancer Res. 2013, 33, 13-20.
45. Briski, K.P.; Patil, G.D. Induction of Fos immunoreactivity labeling in rat forebrain metabolic loci by caudal fourth ventricular infusion of the monocarboxylate transporter inhibitor; alpha-cyano-4-hydroxycinnamic acid. Neuroendocrinology 2005, 82, 49-57.
46. Thornalley, P.J.; Yurek-George, A.; Argirov, O.K. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal; methylglyoxal; and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 2000, 60, 55-65.
47. Baynes, J.W.; Murray, D.B. The metal chelators; trientine and citrate; inhibit the development of cardiac pathology in the Zucker diabetic rat. Exp. Diabetes Res. 2009, 2009, 696378.
48. Mera, K.; Takeo, K.; Izumi, M.; Mruyama, T.; Nagai, R.; Otagiri, M. Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. J. Pharm. Sci. 2010, 99, 1614-1625.
49. Grimm, S.; Horlacher, M.; Catalgol, B.; Hoehn, A.; Reinheckel, T.; Grune, T. Cathepsins D and L reduce the toxicity of advanced glycation end products. Free Radic. Biol. Med. 2012, 52, 1011-1023.
50. Seneviratne, C.; Dombi, G.W.; Liu, W.; Dain, J.A. The in vitro glycation of human serum albumin in the presence of Zn(II). J. Inorg. Biochem. 2011, 105, 1548-1554.
51. Kang, Y.; Edwards, L.G.; Thornalley, P.J. Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis. Leuk. Res. 1996, 20, 397-405.
52. Meeprom, A.; Sompong, W.; Chan, C.B.; Adisakwattana, S. Isoferulic acid; a new anti-glycation agent; inhibits fructose- and glucose-mediated protein glycation in vitro. Molecules 2013, 18, 6439-6454.
53. Witko-Sarsat, V.; Friedlander, M.; Capeillere-Blandin, C.; Nguyen-Khoa, T.; Nguyen, A.T.; Zingraff, J.; Jungers, P.; Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49, 1304-1313.